Welcome to our dedicated page for Atomera SEC filings (Ticker: ATOM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Atomera Incorporated’s (NASDAQ: ATOM) SEC filings, offering a detailed view of how the semiconductor materials and technology licensing company reports its activities as a public issuer. Atomera’s filings include current reports on Form 8-K, annual and quarterly reports, and other documents that describe its Mears Silicon Technology™ (MST®), licensing-focused business model and risk profile.
Recent Form 8-K filings reference quarterly financial results and related investor presentations, as well as disclosures about Atomera’s use of its corporate website and LinkedIn account as channels for distributing material information under Regulation FD. These filings confirm that Atomera’s common stock, par value $0.001, trades on the Nasdaq Capital Market under the symbol ATOM, and they furnish press releases that discuss revenue levels, operating expenses, cash balances and non-GAAP metrics such as adjusted EBITDA.
Investors reviewing Atomera’s 10-K and 10-Q filings can examine risk factors, business descriptions and financial statements that elaborate on its status as an early-stage enterprise with minimal engineering services and licensing revenues to date. These reports typically cover topics such as joint development agreements, integration licenses, capital requirements and protection of proprietary MST technology, trade secrets and know-how.
Through this filings page, users can also monitor ongoing disclosure about collaborations and customer engagements, as many material announcements are cross-referenced in 8-Ks. Stock Titan’s tools surface Atomera’s latest submissions from the SEC’s EDGAR system and can pair them with AI-powered summaries that explain the key points in plain language, helping readers quickly understand the implications of lengthy 10-Ks, 10-Qs, 8-Ks and related exhibits, as well as track any future insider transaction reports on Form 4.
Morgan Stanley Smith Barney LLC Executive Financial Services reported the vesting of 10,075 shares of Common stock under the issuer's equity compensation plan with dates shown 03/01/2026 and 03/02/2026.
The filing lists this vesting alongside a Form 144 securities‑to‑be‑sold entry for Common stock on 03/02/2026; the shares were granted as part of the issuer's equity compensation plan.
Atomera Incorporated reported that CVI Investments, Inc. and Heights Capital Management, Inc. together hold 2,100,000 shares of common stock, representing 5.8% of the class. The filing states there were 36,509,895 shares outstanding as of the completion of the offering per the prospectus supplement filed 02/24/2026.
The filing notes CVI Investments is organized in the Cayman Islands and that Heights Capital Management, Inc., as CVI's investment manager, may exercise shared voting and dispositive power over those shares; both entities disclaim beneficial ownership except for pecuniary interest.
Atomera Incorporated describes its MST® silicon film technology and licensing model for the global semiconductor market, focusing on power, RF, CMOS and emerging compound semiconductor applications. The company licenses process technology, MSTcad® simulation software and integration engineering rather than manufacturing chips itself.
Atomera remains in an early commercialization stage with limited revenue and significant losses, reporting net losses of about $20.2 million in 2025 and an accumulated deficit of roughly $241.7 million. It spent approximately $12.3 million on research and development in 2025 and had about $19.2 million in cash and cash equivalents and working capital of about $17.6 million as of December 31, 2025, later raising roughly $23.6 million in a February 2026 stock offering.
The company highlights JDAs and integration licenses with major foundry, IDM and fabless partners but notes that STMicroelectronics paused qualification of MST in 2025. Atomera reports 21 employees, 119 U.S. and 130 foreign patents with extensive pending applications, and emphasizes cybersecurity, IP protection and risks tied to long adoption cycles, customer concentration, financing needs and stock volatility.
Atomera Incorporated is issuing 5,000,000 shares of common stock in a registered primary offering. The shares are being offered at $5.00 per share for aggregate gross proceeds of $25,000,000, with expected net proceeds of approximately $23,600,000 to be used for working capital and general corporate purposes.
The offering is being made pursuant to a prospectus supplement dated February 23, 2026, with delivery of shares expected on or about February 24, 2026. The company states there were 31,509,895 shares outstanding as of September 30, 2025, which gives an expected post-offering outstanding share count of 36,509,895 shares.
Atomera Incorporated entered a definitive securities purchase agreement with institutional investors for a registered direct offering of 5,000,000 shares of common stock at $5.00 per share, for expected gross proceeds of approximately $25 million before fees and expenses.
The shares are being issued off an effective Form S-3 shelf registration, with closing expected on or about February 24, 2026, subject to customary conditions. Atomera plans to use the net proceeds for working capital and general corporate purposes.
Craig-Hallum Capital Group is acting as sole placement agent, earning a cash fee of 5.0% of gross proceeds plus up to $75,000 of reimbursed expenses. The company agreed to 90-day issuance restrictions, and executives and directors signed 90-day lock-up agreements restricting sales and hedging of Atomera stock.
Atomera Inc CFO Laurencio Francis reported a set of stock transactions. On February 20, 2026, he exercised incentive stock options into 21,834 shares of common stock at $5.70 per share, then sold 21,834 shares at $7.25 per share. After these trades, he directly owned 166,082 shares of Atomera common stock.
Atomera Incorporated reported fourth-quarter and full-year 2025 results, showing a company still in investment mode with modest revenue and continuing losses. In Q4 2025, Atomera posted a net loss of $4.4 million, or $0.14 per share, an improvement from a $5.6 million loss in Q3 2025 and $4.7 million a year earlier, helped by lower operating expenses and higher interest income.
For fiscal 2025, revenue was $65,000, down from $135,000 in 2024, while net loss widened to $20.2 million, or $0.65 per share, compared with a $18.4 million loss, or $0.68 per share, in 2024. Adjusted EBITDA loss increased slightly to $16.1 million from $15.4 million, reflecting sustained spending on research and operations. Atomera ended December 31, 2025 with $19.2 million in cash, cash equivalents and short-term investments and 32.4 million shares outstanding, providing liquidity to support ongoing development despite the lack of significant revenue.
Francis Laurencio submitted a notice to sell 21,834 common shares on 02/20/2026 via a stock option exercise through Morgan Stanley Smith Barney LLC for cash on NASDAQ. The filing also reports prior sales of 4,451 common shares on 12/01/2025 for $10,639.16.
Atomera Incorporated reported fourth-quarter and full-year 2025 results, highlighting both technical progress and ongoing losses as it commercializes its semiconductor materials technology. The company achieved a breakthrough demonstrating manufacturability of its MST on Gate-All-Around structures and has a top 20 semiconductor customer running wafers on GaN with MST.
For the fourth quarter of 2025, Atomera posted a net loss of $4.4 million, or $0.14 per share, improving from a $5.6 million loss, or $0.17 per share, in the prior quarter. Full-year 2025 revenue was $65,000, down from $135,000 in 2024, while net loss widened to $20.2 million, or $0.65 per share, versus $18.4 million, or $0.68 per share, a year earlier. Adjusted EBITDA loss increased to $16.1 million from $15.4 million.
Atomera ended 2025 with $19.2 million in cash, cash equivalents and short-term investments, down from $26.8 million a year earlier, and had 32.4 million shares outstanding. Management emphasized strong interest in MST from advanced transistor and power applications and hosted a webinar to discuss the results and its commercialization efforts.
Atomera Incorporated updated its corporate governance framework when its Board of Directors approved and adopted Second Amended and Restated Bylaws on February 5, 2026. These amended bylaws are intended to reflect recent changes in the Delaware General Corporation Law.
The company states that these revisions do not materially change the disclosures previously made about its former bylaws in registration statements, prospectuses, and reports filed with the SEC, except for limited differences not detailed here. The full text of the amended bylaws is provided as Exhibit 3.1 to this report.